Smith et al.
JOCArticle
0.148 mmol) was added and the solution stirred until judged to
be complete by consumption of the starting material (TLC). The
reaction mixture was then concentrated in vacuo and purified by
column chromatography.
Method C (Using Catalyst II). A Radley’s reaction tube was
charged with a solution of catalyst II (25.0 mg, 24.6 μmol) in
˚
CH2Cl2 (0.5 mL) and powdered molecular sieves (4 A, 125 mg).
After the solution was stirred for 30 min, a solution of
β-ketoester (0.246 mmol) in CH2Cl2 (0.5 mL) was added,
followed by 1b (81.2 mg, 0.295 mg), and the progress of
the reaction was monitored (TLC). When this was completed,
the reaction mixture was then filtered through a plug of
Celite, concentrated in vacuo, and purified by column chro-
matography.
NMR δH (CDCl3) 7.38-7.33 (2H, m), 6.88-6.83 (2H, m),
4.76-4.55 (2H, m), 3.80 (3H, m), 3.10 (1H, d, J 18.0), 2.85
(1H, d, J 18.0), 1.32 (9H, s); NMR δC (CDCl3) 174.1, 173.1,
168.55, 159.5, 130.3, 127.4, 114.0, 85.7, 76.0, 55.3, 42.25, 40.6,
27.5; MS m/z (EI) 335.1369 (Mþ, C17H21NO6 requires
335.1369), 278 (48), 121 (100), 57 (47). Chirapak OD-H column,
hexane/i-PrOH = 90/10, 1 mL/min, 254 nm, tR (minor) = 12.7
min, tR (major) = 13.8 min; [R]25 þ37.8 (c = 0.95, CHCl3,
D
>99% ee).
Crystal data for (S)-20b: C17H21NO6, M = 335.35, mono-
˚
˚
clinic, P21 (no. 4), a = 6.34741(7) A, b = 10.76431(9) A, c =
3
˚
˚
12.86992(13) A, β = 102.2709(10)°, V = 859.254(15) A , Z = 2,
Dc = 1.296 g cm-3, μ(Cu KR) = 0.824 mm-1, T = 173 K,
colorless tablets, Oxford Diffraction Xcalibur PX Ultra dif-
Method D (Ligand Screening). Under a nitrogen atmosphere,
a Radley’s reaction tube was purged with nitrogen and charged
fractometer; 3386 independent measured reflections (Rint =
0.0297), F2 refinement, R1(obs) = 0.0259, wR2(all) = 0.0688,
3221 independent observed absorption-corrected reflections
[|F0| > 4σ(|F0|), 2θmax = 145°], 223 parameters. The absolute
structure of (S)-20b was determined by a combination of
R-factor tests [R1þ = 0.0259, R1- = 0.0262] and by use of the
Flack parameter [xþ = 0.00(12), x- = 1.04(12)]. CCDC765842.
tert-Butyl 3-hydroxy-1-tert-butylsuccinimide-3-carboxylate
(20c, Table 4, entry 15): white crystalline solid; mp 55-56 °C;
IR νmax/cm-1 2980, 1744, 1707, 1370, 1348, 1265, 1172, 1148;
NMR δ H (CDCl3) 3.80 (1H, br s), 3.00 (1H, d, J 17.6), 2.78 (1H,
d, J 17.6), 1.61 (9H, s), 1.50 (9H, s); NMR δC (CDCl3) 175.7,
174.4, 168.8, 85.36, 75.69, 59.2, 40.8, 28.1, 27.7; MS m/z (NH3,
CI) 289.1765 (MNH4þ, C13H25N2O5 requires 289.1763), 233
(23), 217 (11); Chirapak OD-H column, hexane/i-PrOH = 98/2,
1 mL/min, 254 nm, tR (minor) = 11.9 min, tR (major) = 13.6
min; [R]25D þ18.1 (c = 1.10, CHCl3, 68% ee).
with Pd(OTf)2 2H2O40 (5.4 mg, 12.3 μmol), the appropriate
3
ligand (13.5 μmol), and CH2Cl2 (0.4 mL). After the solution was
stirred for 30 min, a solution of 7a (23.4 mg, 0.123 mmol) in
CH2Cl2 (0.1 mL) was added, followed after a further 5 min by a
solution of 1b (40.7 mg, 0.148 mmol) in CH2Cl2 (0.1 mL), and
the solution stirred for 18 h. The reaction mixture was then
concentrated in vacuo, filtered through a plug of silica, and
analyzed by NMR and chiral HPLC.
Benzyl 1-tetralone-2-hydroxy-2-carboxylate (15c, Table 4,
entry 3): white crystalline solid; mp 87-89 °C; IR νmax /cm-1
2936, 1739, 1686, 1602, 1455, 1227, 1189, 907, 725; NMR δH
(CDCl3) 8.07 (1H, dd, J 7.8, 1.2), 7.59-7.52 (1H, td, J 7.6, 1.4),
7.37 (1H, t, J 7.6), 7.33-7.23 (4H, m), 7.18 (2H, m), 5.25 (1H, d,
J 12.4), 5.18 (1H, d, J 12.4), 4.35 (1H, s), 3.15-3.01 (2H, m), 2.75
(1H, dt, J 13.6, 5.0), 2.27 (1H, ddd, J 13.6, 8.8, 6.6); NMR δC
(CDCl3) δ 194.5, 170.4, 143.9, 134.9, 134.3, 130.3, 128.9, 128.5,
128.3, 128.1, 127.7, 127.0, 77.8, 67.5, 32.7, 25.5; MS m/z (EI)
296.1045 (C18H16O4 requires 296.1049), 205 (22), 180 (10), 161
(30), 107 (23), 91 (100). Chirapak AD-H column, hexane/i-
PrOH = 90/10, 1 mL/min, 254 nm, tR (major) = 26.7 min, tR
(minor) = 40.2 min. The optical purity was too low (1%) for
accurate determination of [R]D.
Benzyl 2-hydroxycyclohexanone-2-carboxylate (16, Table 4,
entry 4): colorless oil; IR νmax /cm-1 2947, 1744, 1717, 1455,
1216, 1056, 737, 696; NMR δH (CDCl3) 7.43-7.31 (5H, m),
5.28-5.17 (2H, m), 4.39 (1H, s), 2.72- 2.62 (2H, m), 2.56-2.43
(1H, m), 2.05-1.95 (1H, m), 1.90-1.64 (4H, m); NMR δC
(CDCl3) 207.1, 169.8, 135.0, 128.6, 128.5, 128.1, 80.7, 67.5,
38.8, 37.6, 27.0, 21.9; MS m/z (EI) 248.1044 (C14H16O4 requires
248.1049), 232 (6), 220 (6), 157 (15), 129 (18), 111 (15), 91 (100).
Chiracel OJ-H column, hexane/i-PrOH = 90/10, 1 mL/min, 220
nm, tR (minor) = 27.7 min, tR (major) = 30.7 min; [R]25D -20.6
(c = 1.55, CHCl3, 66% ee).
1,3-Ditert-butoxycarbonyl-3-hydroxysuccinimide (20d, Ta-
ble 4, entry 16): colorless oil; IR νmax/cm-1 2981, 1720, 1370,
1141, 909, 729; NMR δH (CDCl3) 4.25 (1H, m, br, OH), 3.16 (1H,
d, J 18.0), 2.93 (1H, d, J 18.0), 1.58 (9H, s), 1.50 (9H, s); NMR δC
(CDCl3) 170.6, 168.9, 167.7, 145.6, 86.8, 86.3, 76.3, 40.8, 27.7; MS
m/z (NH3, CI) 333.1663 (MNH4 , C14H25N2O7 requires
þ
333.1662), 317 (28), 233 (35); Chirapak AD-H column, hexane/
i-PrOH = 90/10, 1 mL/min, 254 nm, tR (major) = 9.4 min, tR
(minor) = 12.1 min; [R]25D þ0.0 (c = 1.11, CHCl3, 49% ee).
Benzyl 3-phenyl-2-acetylpropionate (25d, Table 5, entry 7):
colorless oil; IR νmax /cm-1 3034, 1717, 1496, 1455, 1268, 1199,
1119, 696; NMR δH (CDCl3) 7.44-7.31 (5H, m), 7.27-7.19
(3H, m), 7.19-7.12 (2H, m), 5.28-5.15 (2H, m), 4.06
(1H, s), 3.44 (1H, d, J 14.2), 3.20 (1H, d, J 14.2), 2.24 (3H, s);
NMR δC (CDCl3) δ 203.7, 170.3, 134.5, 134.4, 130.1, 128.7,
128.7, 128.6, 128.2, 127.1, 84.3, 68.3, 40.7, 25.1; MS m/z
(ammonia, CI) 316.1554 (MNH4 , C18H22NO4 requires
þ
316.1549), 300 (4), 272 (1), 182 (1); Chiracel OJ-H column,
hexane/i-PrOH = 90/10, 1 mL/min, 254 nm, tR (minor) =
25.7 min, tR (major) = 30.5 min; [R]25D þ2.8 (c = 0.70, CHCl3,
32% ee).
N-Benzyl 3-hydroxy-3-(tert-butoxycarbonyl)succinimide (20a,
Table 4, entry 13): white crystalline solid; mp 138-143 °C; IR
ν
max/cm-1 1742, 1715, 1697, 1402, 1185, 1151, 133, 967; NMR
δ
H (CDCl3) 7.44-7.27 (5H, m), 4.77 (1H, d, J 14.0), 4.71 (1H, d,
Ethyl 2-hydroxy-2-phenylacetoacetate (27, Table 6, entry 10):
colorless oil; IR νmax /cm-1 1719, 1359, 124, 1173, 1072, 698;
NMR δH (CDCl3) 7.55 (2H, m), 7.41-7.35 (3H, m), 4.74 (1H, s),
4.37-4.24 (2H, m), 2.22 (3H, s), 1.31 (3H, t, J 7.2); NMR δC
(CDCl3) 203.8, 170.5, 133.3, 128.9, 128.6, 126.5, 84.7, 63.2, 24.3,
21.9; MS m/z (EI) 222.0893 (Mþ, C12H14O4 requires 222.0892),
180 (48), 151 (16), 105 (100), 77 (42); Chiracel OJ-H column,
hexane/i-PrOH = 90/10, 1 mL/min, 254 nm, tR (minor) =
21.2 min, tR (major) = 29.9 min; [R]25D -19.0 (c = 0.21, CHCl3,
27% ee).
J 14.0), 4.09 (1H, s), 3.12 (1H, d, J 18.0), 2.87 (1H, d, J 18.0), 1.34
(9H, s); NMR δC (CDCl3) 174.1, 173.1, 168.5, 135.1, 128.8,
128.7, 128.15, 85.7, 76.0, 42.8, 40.65, 27.5; MS m/z (EI) 305.1256
(Mþ C16H19NO5 requires 305.1263), 249 (28), 205 (34), 91 (52),
57 (100). Chirapak AD-H column, hexane/i-PrOH = 90/10, 1
mL/min, 254 nm, tR (major) = 16.0 min, tR (minor) = 17.7 min;
[R]25D þ18.5 (c = 1.29, CHCl3, 83% ee).
tert-Butyl 3-Hydroxy-1-(4-methoxybenzyl)succinimide-3-car-
boxylate (20b, Table 4, Entry 14). Compound 20b (820 mg,
2.45 mmol) was recrystallized from hot hexane (16 mL) and
EtOAc (18.9 mL) to give the optically pure sample (603 mg, 69%
yield, >99% ee) as a white crystalline solid: mp 136-138 °C; IR
Acknowledgment. We thank EPSRC and Pfizer for stu-
dentship support (A.M.R.S.) and Johnson Matthey plc for
the loan of Pd salts. Gifts of chiral ligands were received
from Solvias, Johnson Matthey, Dow Pharma, Chirotech,
ν
max/cm-1 1739, 1703, 1614, 1588, 1514, 1402, 1180, 1152, 1129;
(40) Murata, S.; Ido, Y. Bull. Chem. Soc. Jpn. 1994, 67, 1746.
J. Org. Chem. Vol. 75, No. 9, 2010 3095